Morning boost: a simple routine may help beat Post-Stroke depression

NCT ID NCT07719517

First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time

Summary

This pilot trial tests whether a six-week behavioral program focused on morning activation can improve mood and daily functioning in adults who have had a stroke and struggle with depressive symptoms. Participants are randomly assigned to either the morning activation program or a general health education program. The study measures feasibility, mood changes, and daily activity patterns to see if this approach is worth testing in larger trials.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a six-week behavioral program called Morning Activation Program that helps stroke survivors establish consistent morning routines and engage in daily activities after waking
What this could lead to
If it works, this could point toward a simple, non-drug way to ease depressive symptoms and improve daily functioning after a stroke.
What could go wrong
This is a very small pilot study with only 30 participants, so results may not apply widely. The program requires active participation and may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSIVE SYMPTOMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The Hong Kong Polytechnic University

    RECRUITING

    Hong Kong, Hong Kong

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.